Equities researchers at Robert W. Baird assumed coverage on shares of Privia Health Group (NASDAQ:PRVA – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $23.00 price target on the stock. Robert W. Baird’s target price would suggest a […]